Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-05-11
Summary
The goal of this study is to observe metabolic features associated with human melanoma tumors.
Conditions
- Melanoma (Skin)
Sponsors & Collaborators
-
University of Texas Southwestern Medical Center
lead OTHER
Principal Investigators
-
Jennifer Gill, MD, PhD · UT Southwestern Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-01
- Primary Completion
- 2028-08-01
- Completion
- 2028-08-01
Countries
- United States
Study Locations
More Related Trials
-
Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
NCT02828202 ·Status: RECRUITING
-
Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma
NCT01425008 ·Status: COMPLETED ·Phase: PHASE1
-
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
NCT03728842 ·Status: ACTIVE_NOT_RECRUITING
-
Inducing Systemic Immunity and Regressions in Metastatic Melanoma
NCT02350972 ·Status: COMPLETED ·Phase: PHASE1
-
Serial Tumour Biopsies and Blood Biomarkers in Melanoma
NCT04493723 ·Status: RECRUITING
-
Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma
NCT05307289 ·Status: RECRUITING ·Phase: NA
-
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
NCT00002860 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Study of TPI 287 for Patients With Metastatic Melanoma
NCT01340729 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes
NCT00463892 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice
NCT05402059 ·Status: UNKNOWN
-
Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.
NCT06994208 ·Status: RECRUITING
-
Real-world Evaluation of the Impact of Baseline Metastases on Clinical Outcomes Among BRAF Positive Metastatic Melanoma Patients
NCT05984615 ·Status: COMPLETED
-
Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study
NCT02780089 ·Status: COMPLETED
-
Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma
NCT01055522 ·Status: TERMINATED ·Phase: PHASE2
-
Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma
NCT01840007 ·Status: COMPLETED ·Phase: PHASE2
-
Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma
NCT03034395 ·Status: COMPLETED ·Phase: NA
-
Impact of Obstructive SAS on Metastatic Potential of Cutaneous Melanoma
NCT02699918 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
NCT03199846 ·Status: COMPLETED
-
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
NCT00004196 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Data Collection for Subjects in MDX-010 Studies
NCT00928031 ·Status: COMPLETED
-
CCI-779 in Treating Patients With Metastatic Melanoma
NCT00022464 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma
NCT01482260 ·Status: COMPLETED
-
Study of Families With Melanoma
NCT00445783 ·Status: UNKNOWN
-
Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic
NCT02094872 ·Status: COMPLETED ·Phase: PHASE2
-
Cutaneous Squamous Cell Carcinoma Staging Study
NCT05695222 ·Status: RECRUITING